-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Immix Biopharma, Inc. quarterly Revenues history and growth rate for Q4 2022.
- Immix Biopharma, Inc. Revenues for the quarter ending December 8, 2022 was $20M.